COCP - Cocrystal Pharma GAAP EPS of -$0.70 misses by $0.21
- Cocrystal Pharma press release ( NASDAQ: COCP ): Q3 GAAP EPS of -$0.70 misses by $0.21 .
- Cocrystal reported unrestricted cash of $42.1 million as of September 30, 2022 compared with $58.7 million as of December 31, 2021.
- Shares +4.38% PM.
For further details see:
Cocrystal Pharma GAAP EPS of -$0.70 misses by $0.21